• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Onkos Surgical

Onkos Surgical wins FDA de novo nod for antibacterial-coated orthopedic implants

April 9, 2024 By Danielle Kirsh

Onkos Surgical this week announced it received FDA de novo approval for its antibacterial coated implants. According to the Parsippany, N.J.-based company, bacterial contamination of a permanent implant could have devastating effects in orthopedic oncology and revision arthroplasty. “Implant contamination is a growing concern to the orthopaedic surgical community,” Dr. Steven Gitelis, chief medical officer, […]

Filed Under: Food & Drug Administration (FDA), News Well, Orthopedics Tagged With: De Novo Clearance, Onkos Surgical, Orthobond

Orthobond wins FDA de novo approval for antibacterial technology that could have vast device applications

April 8, 2024 By Jim Hammerand

Orthobond has secured FDA de novo approval for its Ostaguard antibacterial technology that could one day be used for a wide range of medical devices — and beyond medtech. The Monmouth Junction, New Jersey-based device developer says it’s the first time the FDA has granted a de novo request for a non-eluting coating designed to […]

Filed Under: Featured, Food & Drug Administration (FDA), Implants, News Well, Orthopedic Implants, Orthopedics, Spine Tagged With: De Novo Clearance, FDA, Onkos Surgical, Orthobond, SeaSpine

Onkos wins FDA clearance for 3D-printed pelvic reconstruction system

July 14, 2022 By Chris Newmarker

Onkos Surgical announced today that the FDA has cleared its My3D personalized pelvic reconstruction system. My3D expands Onkos Surgical’s portfolio to include systems to treat pelvic conditions. The Parsippany, New Jeresey–based company said My3D includes 3D-printed implants, instruments and models. There is also an advanced planning service to treat deformity, trauma, disease and revisions. There […]

Filed Under: 3D Printing, 510(k), Featured, Food & Drug Administration (FDA), News Well, Orthopedics, Regulatory/Compliance, Surgical Tagged With: Onkos Surgical

Onkos Surgical raises $26.5M

June 16, 2022 By Sean Whooley

Surgical oncology device maker Onkos Surgical today filed an amendment to an SEC Form D confirming the sale of $26.5 million in equity. The equity offering had its first sale on Aug. 31, 2021 and today reached $26,500,001. That leaves no amount remaining to be sold. According to the amended SEC Form D, 16 investors […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Implants, Oncology, Orthopedics, Surgical Tagged With: Onkos Surgical

Onkos Surgical to acquire Stryker’s Juvenile Tumour System

June 13, 2022 By Sean Whooley

Onkos Surgical announced today that it agreed to acquire the Juvenile Tumour System (JTS) from Stryker (NYSE:SYK). Parsippany, New Jersey–based Onkos entered into a definitive agreement with the orthopedic technology giant over the system designed to enable limb stabilization and growth in pediatric patients affected by bone cancers, severe arthropathy, severe trauma, revisions, oncology and […]

Filed Under: Business/Financial News, Featured, News Well, Oncology, Orthopedics Tagged With: Onkos Surgical, Stryker

Onkos Surgical wins FDA clearance for BioGrip 3D-printed implant

June 22, 2021 By Danielle Kirsh

Onkos Surgical today announced that it received FDA 510(k) clearance for its BioGrip 3D-printed implant technology. The Parsippany, N.J.–based company designed BioGrip to address the clinical challenge of aseptic loosening in musculoskeletal oncology and complex orthopedic limb salvage surgery. It helps provide bone ingrowth at the bone-implant interface. Get the full story on our sister […]

Filed Under: 3D Printing, 510(k), Featured, Food & Drug Administration (FDA), Implants, Oncology, Orthopedics, Regulatory/Compliance Tagged With: Onkos Surgical

Onkos Surgical launches Eleos Proximal Tibia

December 21, 2020 By Danielle Kirsh

Onkos Surgical today said it has launched its new Eleos Proximal Tibia with BioGrip technology. The implant is designed for use in complex tumor and orthopedic reconstructive procedures. It is touted as the first FDA cleared, 3D printed limb salvage replacement. “The new Eleos Proximal Tibia with BioGrip offers features that are intended to help […]

Filed Under: Orthopedics Tagged With: Onkos Surgical

Onkos Surgical raises $7.6m

April 30, 2020 By Sean Whooley

Surgical oncology device developer Onkos Surgical filed an SEC Form D to confirm the sale of nearly $7.6 million in equity. The Parsippany, N.J.-based company made its first sale for the new notice on April 21, having now sold approximately $7.57 million. The total offering amount is $12 million, leaving more than $4.4 million remaining […]

Filed Under: Business/Financial News, Funding Roundup, Oncology, Orthopedics, Surgical Tagged With: Onkos Surgical

Onkos Surgical launches bone scaffolding technology

February 7, 2020 By Danielle Kirsh

Onkos Surgical recently launched its GenVie Magnesium Bone Scaffold. The GenVie is a magnesium-based bone void filler with osteoconductive and high compression strength attributes to promote bone repair and regeneration. It is designed for surgically created osseous defects or osseous defects created from traumatic injury to the bone. “We are excited about the launch of […]

Filed Under: Orthopedics Tagged With: Onkos Surgical

Onkos Surgical partners with Integrum for OPRA Implant System

January 22, 2020 By Danielle Kirsh

Onkos Surgical this week announced it signed a multi-year agreement with Integrum to expand to market for Integrum’s OPRA Implant System. The collaboration is expected to commence immediately and will focus on expanding the U.S. market for Integrum’s Osseoanchored Prostheses for the Rehabilitation of Amputees (OPRA) Implant System. “We are delighted to partner with Dr. […]

Filed Under: Business/Financial News, Orthopedics, Surgical Tagged With: Integrum AB, Onkos Surgical

Bone Solutions, Onkos ink private label deal

August 28, 2019 By Sean Whooley

Bone Solutions said today that it entered into a private label licensing agreement with Onkos Surgical for its OsteoCrete bone void-filling technology. Colleyville, Texas-based BSI’s OsteoCrete is an FDA 510(k)-cleared magnesium-based injectable, moldable solution designed to attaching ligaments and tendons to bone and bone to bone. Parsippany, N.J.-based Onkos Surgical intends to market OsteoCrete under the […]

Filed Under: Distribution, Implants, Orthopedics Tagged With: Bone Solutions Inc., Onkos Surgical

  • Page 1
  • Page 2
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy